Global Personalized Medicine Market Analysis 2019

The Global Personalized Medicine market is expected to reach $3.92 trillion by 2026 growing at a CAGR of 12.1% during the forecast period. Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine. In personalized medicine, diagnostic analysis is often conducted for selecting suitable and best treatments based on the patient’s genetic content or other molecular or cellular analysis. Personalized medicine has the best response and highest safety margin to ensure enhanced patient care by allowing every patient to attain earlier diagnosis, risk assessment, and best treatment. The efficient and advanced technology and Higher prevalence of disease are driving the market growth. However, the higher cost of research and developments is hampering the market. Based on the End User, the hospital's segment is estimated to have a lucrative growth due to the lower cost personalized medicines availability in the hospitals. As the practice of personalized medicine becomes more widespread, hospitals will also experience the need to adapt. That does not mean every hospital and medical centre should try and drive the science, but they should be open to collaborations to facilitate such work. The key vendors mentioned are Abbott Laboratories, Affymetrix Incorporated, Agendia N.V, Agilent Technologies, Inc, Amgen, Inc, Asuragen Incorporated, Bayer Healthcare Pharmaceuticals, Llc, Celera Diagnostics LLC, Celgene Corporation, Roche Diagnostics Corporation, Precision Biologics Incorporated, Siemens Healthcare Diagnostics, Inc, Sigma-Aldrich Corporation, Johnson & Johnson, Novartis AG, Decode Genetics Inc., Exact Science Corporation, Exagen Diagnostics Inc., GE Healthcare, and Genelex Corporation. Products Covered: • Diagnostics • Personalized Medical Care • Personalized Nutrition & Wellness • Therapeutics Technologies Covered: • Metabolomics • Pharmacodynamics • Pharmacogenetics • Pharmacogenomics • Pharmacokinetics • Pharmacoproteomics • Point-of-Care Testing • Stem Cell Therapy Therapeutic Areas Covered: • Autoimmune Diseases • Blood Transfusion Safety • Cancer Management • Cardiovascular Diseases (CVD) • Central Nervous System (CNS) Disorders • Coagulation Therapy • Diabetes • Infectious Diseases • Antiviral • Neurology • Psychiatry • Oncology • Immunology • Respiratory Distribution Channels Covered: • Dietary Care Centers • Hospital's Pharmacies • Retail Pharmacies • Other Distribution Channels Applications Covered: • Biomarker Identification • Clinical Research Applications • Companion Diagnostics • Health Informatics End-Users Covered: • Academic Institutes • Bio and Health Informatics Companies • Clinical Care and Research Laboratories • Contract Research Organizations • Hospitals • Molecular Diagnostic Laboratories and Testing Facilities • Research Laboratories • Service Providers • Partner • Venture Capitalists • Other End Users Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2016 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Personalized Medicine Market, By Product
5.1 Introduction
5.2 Diagnostics
5.3 Personalized Medical Care
5.4 Personalized Nutrition & Wellness
5.5 Therapeutics

6 Global Personalized Medicine Market, By Technology
6.1 Introduction
6.2 Metabolomics
6.3 Pharmacodynamics
6.4 Pharmacogenetics
6.5 Pharmacogenomics
6.6 Pharmacokinetics
6.7 Pharmacoproteomics
6.8 Point-of-Care Testing
6.9 Stem Cell Therapy

7 Global Personalized Medicine Market, By Therapeutic Area
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Blood Transfusion Safety
7.4 Cancer Management
7.5 Cardiovascular Diseases (CVD)
7.6 Central Nervous System (CNS) Disorders
7.7 Coagulation Therapy
7.8 Diabetes
7.9 Infectious Diseases
7.10 Antiviral
7.11 Neurology
7.12 Psychiatry
7.13 Oncology
7.14 Immunology
7.15 Respiratory

8 Global Personalized Medicine Market, By Distribution Channel
8.1 Introduction
8.2 Dietary Care Centers
8.3 Hospital’s Pharmacies
8.4 Retail Pharmacies
8.5 Other Distribution Channels

9 Global Personalized Medicine Market, By Application
9.1 Introduction
9.2 Biomarker Identification
9.3 Clinical Research Applications
9.4 Companion Diagnostics
9.5 Health Informatics

10 Global Personalized Medicine Market, By End-User
10.1 Introduction
10.2 Academic Institutes
10.3 Bio and Health Informatics Companies
10.4 Clinical Care and Research Laboratories
10.5 Contract Research Organizations
10.6 Hospitals
10.7 Molecular Diagnostic Laboratories and Testing Facilities
10.8 Research Laboratories
10.9 Service Providers
10.10 Partner
10.11 Venture Capitalists
10.12 Other End Users

11 Global Personalized Medicine Market, By Geography
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 South America
11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape
13.1 Abbott Laboratories
13.2 Affymetrix Incorporated
13.3 Agendia N.V
13.4 Agilent Technologies, Inc
13.5 Amgen, Inc
13.6 Asuragen Incorporated
13.7 Bayer Healthcare Pharmaceuticals, Llc
13.8 Celera Diagnostics LLC
13.9 Celgene Corporation
13.10 Roche Diagnostics Corporation
13.11 Precision Biologics Incorporated
13.12 Siemens Healthcare Diagnostics, Inc
13.13 Sigma-Aldrich Corporation
13.14 Johnson & Johnson
13.15 Novartis AG
13.16 Decode Genetics Inc.
13.17 Exact Science Corporation
13.18 Exagen Diagnostics Inc.
13.19 GE Healthcare
13.20 Genelex Corporation

List of Data Tables
Table 1 Global Personalized Medicine Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 3 Global Personalized Medicine Market Outlook, By Diagnostics (2016-2026) ($MN)
Table 4 Global Personalized Medicine Market Outlook, By Personalized Medical Care (2016-2026) ($MN)
Table 5 Global Personalized Medicine Market Outlook, By Personalized Nutrition & Wellness (2016-2026) ($MN)
Table 6 Global Personalized Medicine Market Outlook, By Therapeutics (2016-2026) ($MN)
Table 7 Global Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 8 Global Personalized Medicine Market Outlook, By Metabolomics (2016-2026) ($MN)
Table 9 Global Personalized Medicine Market Outlook, By Pharmacodynamics (2016-2026) ($MN)
Table 10 Global Personalized Medicine Market Outlook, By Pharmacogenetics (2016-2026) ($MN)
Table 11 Global Personalized Medicine Market Outlook, By Pharmacogenomics (2016-2026) ($MN)
Table 12 Global Personalized Medicine Market Outlook, By Pharmacokinetics (2016-2026) ($MN)
Table 13 Global Personalized Medicine Market Outlook, By Pharmacoproteomics (2016-2026) ($MN)
Table 14 Global Personalized Medicine Market Outlook, By Point-of-Care Testing (2016-2026) ($MN)
Table 15 Global Personalized Medicine Market Outlook, By Stem Cell Therapy (2016-2026) ($MN)
Table 16 Global Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 17 Global Personalized Medicine Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
Table 18 Global Personalized Medicine Market Outlook, By Blood Transfusion Safety (2016-2026) ($MN)
Table 19 Global Personalized Medicine Market Outlook, By Cancer Management (2016-2026) ($MN)
Table 20 Global Personalized Medicine Market Outlook, By Cardiovascular Diseases (CVD) (2016-2026) ($MN)
Table 21 Global Personalized Medicine Market Outlook, By Central Nervous System (CNS) Disorders (2016-2026) ($MN)
Table 22 Global Personalized Medicine Market Outlook, By Coagulation Therapy (2016-2026) ($MN)
Table 23 Global Personalized Medicine Market Outlook, By Diabetes (2016-2026) ($MN)
Table 24 Global Personalized Medicine Market Outlook, By Infectious Diseases (2016-2026) ($MN)
Table 25 Global Personalized Medicine Market Outlook, By Antiviral (2016-2026) ($MN)
Table 26 Global Personalized Medicine Market Outlook, By Neurology (2016-2026) ($MN)
Table 27 Global Personalized Medicine Market Outlook, By Psychiatry (2016-2026) ($MN)
Table 28 Global Personalized Medicine Market Outlook, By Oncology (2016-2026) ($MN)
Table 29 Global Personalized Medicine Market Outlook, By Immunology (2016-2026) ($MN)
Table 30 Global Personalized Medicine Market Outlook, By Respiratory (2016-2026) ($MN)
Table 31 Global Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 32 Global Personalized Medicine Market Outlook, By Dietary Care Centers (2016-2026) ($MN)
Table 33 Global Personalized Medicine Market Outlook, By Hospital’s Pharmacies (2016-2026) ($MN)
Table 34 Global Personalized Medicine Market Outlook, By Retail Pharmacies (2016-2026) ($MN)
Table 35 Global Personalized Medicine Market Outlook, By Other Distribution Channels (2016-2026) ($MN)
Table 36 Global Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 37 Global Personalized Medicine Market Outlook, By Biomarker Identification (2016-2026) ($MN)
Table 38 Global Personalized Medicine Market Outlook, By Clinical Research Applications (2016-2026) ($MN)
Table 39 Global Personalized Medicine Market Outlook, By Companion Diagnostics (2016-2026) ($MN)
Table 40 Global Personalized Medicine Market Outlook, By Health Informatics (2016-2026) ($MN)
Table 41 Global Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)
Table 42 Global Personalized Medicine Market Outlook, By Academic Institutes (2016-2026) ($MN)
Table 43 Global Personalized Medicine Market Outlook, By Bio and Health Informatics Companies (2016-2026) ($MN)
Table 44 Global Personalized Medicine Market Outlook, By Clinical Care and Research Laboratories (2016-2026) ($MN)
Table 45 Global Personalized Medicine Market Outlook, By Contract Research Organizations (2016-2026) ($MN)
Table 46 Global Personalized Medicine Market Outlook, By Hospitals (2016-2026) ($MN)
Table 47 Global Personalized Medicine Market Outlook, By Molecular Diagnostic Laboratories and Testing Facilities (2016-2026) ($MN)
Table 48 Global Personalized Medicine Market Outlook, By Research Laboratories (2016-2026) ($MN)
Table 49 Global Personalized Medicine Market Outlook, By Service Providers (2016-2026) ($MN)
Table 50 Global Personalized Medicine Market Outlook, By Partner (2016-2026) ($MN)
Table 51 Global Personalized Medicine Market Outlook, By Venture Capitalists (2016-2026) ($MN)
Table 52 Global Personalized Medicine Market Outlook, By Other End Users (2016-2026) ($MN)
Table 53 North America Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 54 North America Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 55 North America Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 56 North America Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 57 North America Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 58 North America Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)
Table 59 Europe Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 60 Europe Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 61 Europe Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 62 Europe Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 63 Europe Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 64 Europe Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)
Table 65 Asia Pacific Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 66 Asia Pacific Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 67 Asia Pacific Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 68 Asia Pacific Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 69 Asia Pacific Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 70 Asia Pacific Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)
Table 71 South America Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 72 South America Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 73 South America Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 74 South America Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 75 South America Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 76 South America Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)
Table 77 Middle East & Africa Personalized Medicine Market Outlook, By Product (2016-2026) ($MN)
Table 78 Middle East & Africa Personalized Medicine Market Outlook, By Technology (2016-2026) ($MN)
Table 79 Middle East & Africa Personalized Medicine Market Outlook, By Therapeutic Area (2016-2026) ($MN)
Table 80 Middle East & Africa Personalized Medicine Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 81 Middle East & Africa Personalized Medicine Market Outlook, By Application (2016-2026) ($MN)
Table 82 Middle East & Africa Personalized Medicine Market Outlook, By End-User (2016-2026) ($MN)